StockTipsArenaBeta

BUY GlaxoSmithKline Pharmaceuticals Limited — Akshay Bhagwat, JM Financial

BUYGlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals share price target & all analyst calls

byAkshay Bhagwat, JM FinancialHorizon: NA (inferred Swing (≤2wk))18 Aug 2026via ET Now (Live)

Entry₹2,877.3Inferred
Target₹2,975
Total upside +3.40% (call closed)
Stop lossNot given
Exit₹2,97519 Aug 2026, 9:55 am
Target hit+3.40%0.00%upside left
Follow Akshay Bhagwat for new calls(23% target hit, 115 closed calls)Get alertsWatch GLAXO for new buy/sell callsGet alertsSee 150 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 19 Aug 2026
5 supporting1 neutral0 opposing
Supports the BUY call (5)

GSK India Shares Rise Amid Strong FY26 Results and Dividend

NewsGoogle News·18 Aug · today

(opens in new tab)

GSK India Share Price: शेअर ₹2,758 वर, ₹57 डिव्हिडंड आणि दमदार प्रॉफिटची बातमी

NewsGoogle News·18 Aug · today

(opens in new tab)

GSK India Share Price: ਨਿਵੇਸ਼ਕਾਂ ਦੀ ਹੋਈ ਮੌਜ! FY26 ਦੇ ਸ਼ਾਨਦਾਰ ਨਤੀਜੇ, **₹57** ਡਿਵੀਡੈਂਡ ਦਾ ਐਲਾਨ

NewsGoogle News·18 Aug · today

(opens in new tab)

GSK ఇండియా షేర్ ర్యాలీ: FY26 ఫలితాలు, డివిడెండ్ తో ఇన్వెస్టర్లకు ఊరట

NewsGoogle News·18 Aug · today

(opens in new tab)

GlaxoSmithKline Pharma Shares Rise 2% After Q1 Results

NewsGoogle News·13 Aug · 5d ago

(opens in new tab)
Neutral / worth noting (1)

GSK India seeks shareholder approval for MD re-appointment, new director

NewsGoogle News·13 Aug · 5d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on GlaxoSmithKline Pharmaceuticals

All analyst calls on GlaxoSmithKline Pharmaceuticals

More from Akshay Bhagwat, JM Financial

Every call and its outcome